Corriere della Sera – Economia

30 September, 2024

Quality, innovation, and product diversification remain crucial to further growth in the nutraceutical sector, and the development of cosmetics - Fine Foods & Pharmaceuticals N.T.M. S.p.A.’s newest business unit. Along with this, we saw increased production capacity, bolstered by the expansion of the Brembate plant. This brings promising growth prospects for the pharmaceutical division, distinguished by its strong international presence.

With these words, newly appointed CEO Pietro Oriani, who took office just a few weeks ago, emphasised how research, investment, and strategic synergies will be key to ensuring Fine Foods sustains a growth rate that recently doubled compared to its industry peers.

Oriani said: “The goal is to maintain this growth in the coming years, ensuring profitability that aligns with the high standards of our production”.

More details and full article here 

Eco di Bergamo - 14 September 2024

There is potential for growth across all sectors in which the Group operates, with new investments in progress. According to CEO Giorgio Ferraris, the analysis of the first-half results for Fine Foods & Pharmaceuticals N.T.M. S.p.A. showed a promising outlook for sustained revenue and margin growth over the coming years.

The results for the first half of 2024 confirmed these positive prospects, showcasing a record EBITDA of €16 million (+27%) and margins of 13%.

Revenue for the half year reached €122.8 million, reaffirming Fine Foods' position as a leader in the contract manufacturing of nutraceuticals, pharmaceuticals, and cosmetics.

Details and full article HERE

Milano Finanza, September 18 2024

Fine Foods & Pharmaceuticals N.T.M. S.p.A. reported a turnover of €122.8 million and a profit of €4.5 million for the first half of the year. These results highlight the group's growth as a leader in contract production for the nutraceutical, pharmaceutical, and cosmetics industries. Notably, EBITDA reached €16 million, a 27% increase, and EBIT rose from €448,000 to €8.3 million. Former Group General Manager Pietro Oriani was co-opted and appointed as Director and CEO.

Details and full article here

Fine Foods once again participated in the StraBergamo non-competitive march, inviting colleagues to join in and promote health and well-being.

The event was part of the Workplace Health Promotion (WHP) programme.

A total of 140 employees took part in the StraBergamo march, earning fourth place as the largest group, collectively covering 1,575 km.

Fine Foods will continue its support of the Italian Association for Cancer Research (AIRC) by donating a symbolic amount for every kilometre run by participating employees.

Eco.Bergamo - August-September 2024

An ever-evolving sector, both nationally and globally. The Italian market's success is defined by a relentless pursuit of quality, a cornerstone in the production of Fine Foods & Pharmaceuticals N.T.M. S.p.A., which drove the Nutraceuticals Business Unit to achieve a 29.4% growth last year.

A market experiencing continuous growth and distinguished by a quality that attracts the most economically advanced markets. This is the Italian Nutraceutical sector profile, as highlighted in an interview with the Società Italiana di Nutraceutica President Professor Arrigo Cicero.

Nutraceutics is applied in various fields, such as enhancing performance or managing subclinical risk factors, and is widely used to supplement nutrition for greater bodily benefits.

According to Cicero, the sector still has many growth prospects and challenges, due to existing regulatory, scientific, and commercial limitations that hinder the effective communication of these products' potential and qualities.

The global market for food supplements was €120 billion in 2023, continuing its steady growth in recent years. The Italian market stands out as the largest, with a strong emphasis on product quality. Quality is a consistent hallmark throughout Fine Foods' production chain and is key to the success of its products.

Fine Foods is synonymous with innovation in the sector. Many innovations were showcased at the recent Vitafoods event in Geneva, including an expanded range of products that combines prebiotics, probiotics, and postbiotics into a single solution. Additionally, a new generation of capsule products was introduced, providing new possibilities for formulation and administration.

Details and full article here

Eco.bergamo - Eco di Bergamo supplement 16 June 2024

 

The European Union, in its European Biodiversity Strategy for 2030, has set an ambitious goal to plant a minimum of three billion trees.

This involves the public and private sectors, with companies playing a pivotal role.

Among these, Fine Foods & Pharmaceuticals N.T.M. S.p.A. is consistently focused on ESG issues. In line with the expansion of its Verdellino production facility, the company initiated a project to provide and plant various tree species across three areas in the municipality.

Fine Foods & Pharmaceuticals N.T.M. S.p.A. CEO Giorgio Ferraris said: "These areas will be maintained as green spaces and will be accessible to the public." The initiative reflects Fine Foods' commitment to the six sustainability pillars: ethics and governance, people, environment, sustainable products, supply chain and land development.

 

Read the article for further details.

Corriere della Sera - Imprese - 10 June 2024

 

In Q1 2024, the health sector's manufacturing company obtained margins in the double digits, surpassing its performance in 2023.

The group's margins for Q1 2024 have surpassed previous records, and the company is on track to meet its ambitious goals, which align with analysts' predictions.

This growth spans all three divisions – nutraceuticals, pharmaceuticals and cosmetics – and is supported by strategic investments to boost production capabilities. This includes enlarging existing (Nutra), and building new facilities (Pharma), and engaging the CDMO in the innovation process to enhance the market competitiveness of its customers.

 

Read the article for further details.

Eco di Bergamo - 11 June 2024

 

For the second consecutive year, Fine Foods & Pharmaceuticals N.T.M. S.p.A organised the "Write a review and win" literary competition for its employees.

Broadening employees’ horizon and enhancing their critical thinking. This is the philosophy behind the awards for the top two book reviews.

Fine Foods’ employees received complimentary copies of the books for review, with 48 employees participating in the contest.

The award ceremony was held in the Crespi d'Adda Auditorium, with author Alessandra Selmi, and included a company-sponsored guided tour of the workers' village for all attendees.

The empowerment of its workforce is a cornerstone of the Zingonia group's success.

 

Find out more here.

L’Eco di Bergamo - 31 May 2024

 

The Fine Foods & Pharmaceuticals N.T.M. S.p.A. Shareholders' meeting approved the Financial Statements for 2023, dividend distribution and appointed the new Board of Directors with Chairman Marco Francesco Eigenmann, and new Board of Statutory Auditors for the 2024-2026 three-year period.

The Board confirmed Giorgio Ferraris as Group CEO.

 

Read the article in L'Eco di Bergamo.

L'Eco di Bergamo, Economy - 16 May 2024

 

Q1 2024 closed with consolidated revenue of € 65.6 million, in line with the January-March period of 2023 - a record quarter due to an exceptional turnover increase.

Fine Foods & Pharmaceuticals N.T.M. S.p.A. CEO Giorgio Ferraris said: "Q1 2024, with its revenue in line with Q1 2023, showed a double-digit growth in Ebitda and increasing margins. This highlighted a reliable organisational management."

The financial well-being of the company is reflected in the increased bonus given to employees this year, included in the May salary, which was gross € 1,727, a significant rise from the previous year's gross bonus of approximately € 820. Consolidated revenue for 2023 was € 251.8 million, up 21.7% compared to € 206.9 million in 2022, and EBITDA 2023 saw a +44.5% increase to € 22.3 million from € 15.4 million in 2022.

The year 2023 was remarkable, with Fine Foods achieving a double-digit growth. The group's average growth over the past 10 years was 11 per cent against reference markets which grew at around five per cent: Ferraris said: "The market is recognising our efforts."

The Group received 11,350 CVs in 2023, confirming Fine Foods as an attractive place to work.

 

Read more in Giorgio Ferraris' interview with L'Eco di Bergamo.